Table 1 of Simpson, Mol Vis 2000; 6:178-183.


Table 1. Oligonucleotide primer sequences and rapid amplification conditions

The length of the specific amplification products and their approximate Tm are indicated (these varied ±0.3 °C depending on the template). *Primers may be suitable for use with murine (M) or human sequences (H). Accession numbers are given for the gene sequences from which primers are derived (certain sequences contain mismatches with the primers but have been shown to be amplified effectively). The asterisk ("*") marks an alternatively spliced product.

    Gene M/H*        Primer sequences(5'-3')   MgCl2   Anneal       Product
   (Accession)         Forward and Reverse     (mM)     temp       bp &  Tm
------------------   -----------------------   -----   ------   ---------------

28S rRNA (M/H)       TTGAAAATCCGGGGGAGAG         4       54     100
X00525, M11167       ACATTGTTCCAACATGCCAG                       87.1(M)86.9(H)

AGE-R3 (MAC-2) (H)   GTTGCCTTCCACTTTAACCC        4       54     181
M35368               CATTCACTGCAACCTTGAAG                       81.3(H)

ARP (36B4) (M/H)     CGACCTGGAAGTCCAACTAC        4       53     109
X15267, M17885       ATCTGCTGCATCTGCTTG                         82.4(M)80.5(H)

Cathepsin-D (M)      ACAACAGTGACAAGTCCAG         3       55     321
X53337               TGTTCAGGTAGAAGGAGAAG                       91.2(M)

Caveolin (M/H)       TACAAGCCCAACAACAAG          5       55     209
U07645/Z18951        ACAGTGAAGGTGGTGAAG                         87.1(H)

Cyclin D2 (M)        CTTCCAAGCTGAAAGAGACC        4       53     111
M83749               TACCCAACACTACCAGTTCC                       85.5(M)

Cyclophilin (H)      CTCCTTTGAGCTGTTTGCAG        4       55     325
Y00052               CACCACATGCTTGCCATCC                        86.0(H)

GAPDH (M)            AACGACCCCTTCATTGAC          4       57     191
M32599               TCCACGACATACTCAGCAC                        86.6(M)

HIF (M/H)            ACAAGTCACCACAGGACAG         3       52     168
AF003695/U22431      AGGGAGAAAATCAAGTCG                         83.1(M)

Laminin B1 (H)       ACATTGACACGACAGACCC         4       56     231
NM_002291/M61951     GAAGACACAAGCACTGACC                        88.2(H)

LR67 (M/H)           TCACTAACCAGATCCAAGC         4       55     350
J02870, X15005       CTTGGTCACAGCCTTCTC                         88.9(M)83.1(H)

MAC 1  (M)           GATGAGACAAAGAACAACACAC      4       55     208
X07640               TGAAGAACCTCTGAGCATCC                       86.2(M)

NRL (M)              AGTCCCTTGGCTATGGAATATG      4       54     147
L14935               ACTGAAGGTGGGTGAAGGAG                       87.5(M)

PDGFA (M/H)          GTCCAGGTGAGGTTAGAGG         4       57     210/273*
M29464, X03795       CACGGAGGAGAACAAAGAC                        88.8(M)

PDGFB (M/H)          AAGCACACGCATGACAAG          5       55     109
X02811               GGGGCAATACAGCAAATAC                        87.5(M)

PlGF (M)             ACAGAAGTGGAAGTGGTG          4       56     503
X80171               GGCTAATAAATAGAGGGTAGG                      87.2(M)

Rhodopsin (M)        ACACCACTCAACTACATCC         5       57     463
M55171 (U22180)      CGTAGCAGAAGAAGATGAC                        90.3(M)

VEGF (M)             TTACTGCTGTACCTCCACC         4       55     189
S38083               ACAGGACGGCTTGAAGATG                        87.2(M)

VEGF (H)             CGAAACCATGAACTTTCTGC        4       55     302
M32977               CCTCAGTGGGCACACACTCC                       88.5(H)

VEGFD (M)            ACCTCCTACATCTCCAAAC         3       56     422
D89628               TCCAGACTTTCTTTGCAC                         86.0(M)

Simpson, Mol Vis 2000; 6:178-183 <http://www.molvis.org/molvis/v6/a24/>
©2000 Molecular Vision <http://www.molvis.org/molvis/>
ISSN 1090-0535